Development of a screening tool for cardiac involvement in the Sarcoidosis population using cardiac magnetic resonance imaging (MRI)

Development of a screening tool for cardiac involvement in the Sarcoidosis population using cardiac magnetic resonance imaging (MRI) as the gold standard: an observational study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN86576368

Enrollment

Registered

2014-03-14

Start date

2013-09-09

Completion date

Unknown

Last updated

2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcoidosis Haematological Disorders Sarcoidosis, unspecified

Interventions

Patients will be selected from the known sarcoid population at Chester. Patients will be prospectively recruited following new diagnosis of non-cardiac sarcoidosis. They will be put through a screenin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with known Sarcoidosis 2. Male and female, aged 18-65 years

Exclusion criteria

Exclusion criteria: 1. Contraindication for cardiac MRI 2. Any other cardiovascular disease (an exercise tolerance test will be done on all participants to assess for ischaemic heart disease)

Design outcomes

Primary

Measure	Time frame
Presence of cardiac sarcoid as per cardiac MRI, measured at baseline and 1, 6 and 12 months following baseline investigations	—

Secondary

Measure	Time frame
1. Biomarkers 2. ECG and Echo findings Measured at baseline and 1, 6 and 12 months following baseline investigations.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026